Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma

Gilhyang KIM; Yul-Ri CHUNG; Bohyun KIM; Boram SONG; Kyung-Chul MOON.
Journal of Pathology and Translational Medicine ; : 436-441, 2016.
Artículo en Inglés | WPRIM | ID: wpr-53509

Documentos relacionados

  1. [Design and materials for ureteral stents: past, present and future].
  2. PROGNOSTIC SIGNIFICANCE OF METABOLISM INDICATORS OF CONNECTIVE TISSUE IN PATIENTS WITH UPPER URINARY TRACT OBSTRUCTION.
  3. Substances Secreted by <i>Lactobacillus</i> spp. from the Urinary Tract Microbiota Play a Protective Role against <i>Proteus mirabilis</i> Infections and Their Complications.
  4. Re: Cryobiopsy in the Upper Urinary Tract: Preclinical Evaluation of a Novel Device.
  5. Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study.
  6. ABT-263 exerts a protective effect on upper urinary tract damage by alleviating neurogenic bladder fibrosis.
  7. A Perspective of the Urinary Microbiome in Lower Urinary Tract Infections - A Review.
  8. Microbial Biocatalysis within Us: The Underexplored Xenobiotic Biotransformation Potential of the Urinary Tract Microbiota.
  9. [PROTEINURIA IN PATIENTS WITH ACUTE URINARY TRACT OBSTRUCTION].
  10. [Lower urinary tract disorders in men: which management?]